Sahajanand Medical Technologies IPO Details
| IPO Open Date | October 15, 2026 |
| IPO Close Date | October 19, 2026 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹327 to ₹344 Per Share |
| Issue Size | Approx ₹475.5 Crores |
| Offer for Sale: | Approx 1,38,22,116 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Sahajanand Medical Technologies IPO Market Lot
The Sahajanand Medical Technologies IPO minimum market lot is 43 shares with ₹14,792 application amount. The retail investors can apply up-to 13 lots with 559 shares of ₹1,92,296 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 43 | ₹14,792 |
| Retail Maximum | 13 | 559 | ₹1,92,296 |
| S-HNI Minimum | 14 | 602 | ₹2,07,088 |
| S-HNI Maximum | 67 | 2881 | ₹9,91,064 |
| B-HNI Minimum | 68 | 2924 | ₹10,05,856 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
Sahajanand Medical Technologies IPO Anchor Investors
| Anchor Bidding Date | 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | 2026 |
| lock-in period end date 50% shares (90 Days) | 2026 |
Sahajanand Medical Technologies IPO Dates
The Sahajanand Medical Technologies IPO date is October 15 and the close date is October 19. The Sahajanand Medical Technologies IPO allotment will be finalized on October 21 and the IPO listing on October 23.
| IPO Open Date: | October 15, 2026 |
| IPO Close Date: | October 19, 2026 |
| Basis of Allotment: | October 21, 2026 |
| Refunds: | October 22, 2026 |
| Credit to Demat Account: | October 22, 2026 |
| IPO Listing Date: | October 23, 2026 |
Promoters and Holding Pattern
The promoters of the company are Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust.
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
| Promoter and Promoter Group | – | 40.82% | – | 36.2% |
| Others* | – | 59.18% | – | 63.80% |
| Total | 10,16,46,778 | 100% | 10,16,46,778 | 100% |
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
| – | ₹- |
| – | ₹- |
| – | ₹- |
About Sahajanand Medical Technologies
Incorporated in 2001, Sahajanand Medical Technologies is a medical device firm that focuses on Class III and Class C/D devices, mainly working in the fields of vascular and structural heart intervention. The company was the first globally to achieve CE certification for a drug-eluting stent (DES) with a biodegradable polymer, Infinnium. Its product range is divided into 3 main categories: Vascular Intervention (VI), Structural Heart (SH), and other products.
Sahajanand operates two R&D centers, one in India & one in Thailand, backed by a team of 102 professionals such as biomedical engineers and clinical research specialists. Moreover, its key products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 72 clinical studies and are widely known in over 76 countries across Europe, Asia, and other regions.
Company Financials
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2024 | ₹908.59 | ₹875.50 | ₹7.35 | ₹970.58 |
| 2025 | ₹1,035.96 | ₹980.12 | ₹25.15 | ₹1,094.90 |
| 2026 | ₹1218.73 | ₹1138.43 | ₹69.08 | ₹1276.43 |
| June 2026 | ₹354.33 | ₹330.05 | ₹15.09 | ₹1308.100 |
Company Valuation – FY2026
Check Sahajanand Medical Technologies IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | -% |
| ROCE: | 11.57% |
| EBITDA Margin: | 14.10% |
| PAT Margin: | 5.71% |
| Debt to equity ratio: | – |
| Earning Per Share (EPS): | ₹6.67 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 10.60% |
| Net Asset Value (NAV): | ₹62.76 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Poly Medicure Limited | 31.79 | 51.40 | 10.37% | 306.40 | 1875.26 Cr. |
| Laxmi Dental Limited | 5.27 | 36.35 | 11.91% | 44.27 | 277.86 Cr. |
IPO Lead Managers aka Merchant Bankers
- Motilal Oswal Investment Advisors Ltd.
- Avendus Capital Pvt.Ltd.
- HSBC Securities & Capital Markets (India) Pvt.Ltd.
- Nuvama Wealth Management Ltd.
Company Address
Sahajanand Medical Technologies Ltd.
Sahajanand Estate, Wakharia Wadi,
NR. Dabholi Char Rasta
Nani Ved, Ved Road
Surat, Gujarat, 395004
Phone: 022 49564000
Email: [email protected]
Website: http://www.smtpl.com/
IPO Registrar
MUFG Intime India Pvt. Ltd.
Phone: 022-49186000
Email: [email protected]
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Sahajanand Medical Technologies IPO FAQs
What is Sahajanand Medical Technologies IPO?
When Sahajanand Medical Technologies IPO will open for subscription?
What is Sahajanand Medical Technologies IPO Investors Portion?
How to Apply the Sahajanand Medical Technologies IPO?
What is Sahajanand Medical Technologies IPO Issue Size?
What is Sahajanand Medical Technologies IPO Price Band?
What is Sahajanand Medical Technologies IPO Lot Size?
What is the Sahajanand Medical Technologies IPO Allotment Date?
What is the Sahajanand Medical Technologies IPO Listing Date?
Note: The Sahajanand Medical Technologies IPO price band and date are officially announced. The (Sahajanand Medical Technologies IPO grey market premium) will be added to the IPO GMP page as it will start).
